more_reports

The Latest Medical Devices Articles from Streetwise Reports

Bothell, WA Bio Co. Poised for 17-20% Revenue Growth in 2026 as Cell Therapy Market Expands

Research Report
  ()
BioLife Solutions Inc. (BLFS:NASDAQ) reported strong 2025 results. The company is now a pure-play cell processing business, expecting double-digit growth driven by expanding cell and gene therapy adoption, according to an H.C. Wainwright & Co. research note.
Tags: Medical DevicesBiotechnology / Pharmaceuticals

Medical Co.'s TULSA-PRO Installed Base Growth and CAPTAIN Trial Data Could Accelerate Adoption in 2026"

Research Report
  ()
Leede Financial maintained its rating on Profound Medical Corp. (PROF:NASDAQ; PRN:TSX), citing strong TULSA-PRO capital sales, expanding installed base, and upcoming CAPTAIN trial results at EAU meeting as key catalysts.
Tags: Medical Devices

CleanTech Company Advances FDA-Cleared Solution Toward Big Gains

  ()
Clean technology and life sciences company BioLargo Inc. (BLGO:OTCQX) announces that its subsidiary, Clyra Medical Technologies, Inc., has received its first commercial stocking order for ViaCLYR, its FDA-cleared wound irrigation solution. Read why one analyst believes the company has made significant progress in several initiatives.
Tags: Medical DevicesBiotechnology / Pharmaceuticals

Clean Tech Developer Sees Massive Opportunity in PFAS Treatment

  ()
BioLargo Inc. (BLGO:OTCQX) announces that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been installed in New Jersey. Find out why the company sees massive upside for its products.
Tags: Healthcare ServicesMedical DevicesBattery MetalsSpecial SituationsTechnology

Environmental Firm Finds High-Value Position in PFAS Remediation Industry

  ()
BioLargo Inc. (BLGO:OTCQX) has announced the installation of its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system in New Jersey. Discover why the company anticipates significant potential for its products.
Tags: TechnologySpecial SituationsMedical DevicesHealthcare ServicesBattery Metals

Biotech Co. Expands Testing Tied to its Cell Pouch Bio-hybrid Organ

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTC; PSH:XETRA) seeks to determine how a newly developed immunosuppressive agent and, separately, how a different type of islet will work in conjunction with cell implantation via its proven Cell Pouch Bio-hybrid Organ, noted a Leede Financial Inc. report. Read on to learn more about what this Speculative Buy-rated company is working on.
Tags: Medical Devices

Analyst: Scientific Instrument Co.'s Q3/25 Results 'Soft'

Research Report
  ()
Nanalysis Scientific Corp. (NSCI:TSX.V; NSCIF:OTC; 1N1:FSE) has its price target lowered as a result, but is expected to improve its financials in the near term, noted a Leede Financial Inc. report.
Tags: Medical Devices

Clean Tech Co.: Wound Care Subsidiary Set to Take Off; 3Q Results

  ()
Clean technology innovation company BioLargo Inc. releases its financial and operational results for the three- and nine-month periods ending September 30. It also has announced an agreement to distribute its cutting-edge wound irrigation solution nationally.
Tags: Healthcare ServicesMedical Devices

Cleantech Co. Advances Antimicrobial Wound Care Breakthrough

  ()
Cleantech innovation company BioLargo Inc. (BLGO:OTCQX) announced that subsidiary Clyra Medical Technologies is making significant strides. Read why one analyst says the technology is on "the cusp of commercialization."
Tags: Medical DevicesLife Sciences Tools & Diagnostics

Clean Tech Co.'s 'Forever Chemical' Solution Is a PFAS Breakthrough

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announced compelling new findings about its proprietary Aqueous Electrostatic Concentration (AEC) "forever chemicals" solution. Read to discover why one expert thinks the breakthrough is important to the company's future.
Tags: Medical DevicesHealthcare Services

Showing Results: 1 to 10 of 10